The study of a relatively large group of juvenile pediatric spondyloarthritis patients revealed there’s a need for more accurate classification criteria for ... Read more
Improvements in supportive care and access to more information are needed by juvenile idiopathic arthritis (JIA) patients, based on a survey ... Read more
Considerable variability exists in how patients with pediatric rheumatic diseases are treated in clinical practice, making it hard to determine which ... Read more
Imraldi, an adalimumab biosimilar referencing Abbvie’s Humira, has been approved by the European Commission, which means it can now be marketed in ... Read more
